Decreased PSA levels in prostate cancer patients may have confounding factors, including the concomitant use of medical therapies, such as hormones, statins and non-steroidal anti-inflammatory drugs, and/or a higher BMI. The gene discussed is KLK3; the disease is prostate carcinoma.